NCT04389918View on ClinicalTrials.gov

Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

February 26, 2024

Study Completion Date

February 26, 2024

Conditions
Prostate Cancer
Interventions
OTHER

Tality

Synthetic meal replacements, delivered in many varieties of 400 kCal packets, Manufacturer: Filtricine, Inc.

Trial Locations (1)

94304

Stanford University, Stanford

All Listed Sponsors
collaborator

Filtricine Inc.

UNKNOWN

lead

Stanford University

OTHER

NCT04389918 - Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer | Biotech Hunter | Biotech Hunter